CD34 and acute myeloid leukemia: We first analyzed the differentially expressed genes in AML patients compared with the normal controls and during the in vitro myeloid differentiation of CD34+ HSPCs, and then mapped the genes to the RBP DataBase, and finally got the differentially expressed RBPs (Fig. 1a, left).